about
Identification and structure of the nerve growth factor binding site on TrkAExpression of recombinant extracellular domain of the type II transforming growth factor-beta receptor: utilization in a modified enzyme-linked immunoabsorbent assay to screen TGF-beta agonists and antagonists.TrkAd5: A novel therapeutic agent for treatment of inflammatory pain and asthma.16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem BrainClinical relevance of the neurotrophins and their receptors.The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO).Neurotrophins and neurodegeneration.The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer's disease.Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discovery.Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF)Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptorsTargeting nerve growth factor in pain: what is the therapeutic potential?GDNF, NGF and BDNF as therapeutic options for neurodegeneration.Stepwise, non-adherent differentiation of human pluripotent stem cells to generate basal forebrain cholinergic neurons via hedgehog signaling.Familial Alzheimer's disease presenilin 1 mutation M146V increases gamma secretase cutting of p75NTR in vitro.alpha- and beta-secretase: profound changes in Alzheimer's disease.Decrease in bladder overactivity with REN1820 in rats with cyclophosphamide induced cystitis.Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis.VEGFR1 and VEGFR2 in Alzheimer's Disease.Premorbid effects of APOE on synaptic proteins in human temporal neocortex.Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint painPulmonary distribution, regulation, and functional role of Trk receptors in a murine model of asthmaMeasurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay
P50
Q27630756-9E1EA2A0-4335-4542-A2E4-45505D925101Q30657157-64C49236-6B67-4E13-BCA8-A6FD1F4256CBQ33227063-BB282F24-789C-4D90-9C23-881BFC1DFC8EQ33813209-6267C396-484B-475E-9182-BE1786582A68Q34484451-D688BF8C-63C0-4710-BB10-E5B17A85B59FQ35044823-B2542C38-3A8C-48E9-8F3F-E30696986DA7Q35145450-658A309B-21D3-46E1-BDF4-D01F93E32834Q35225403-AB25E37C-2C8A-473C-88BB-C789C91CFBACQ35858432-BB4EEDC4-AA4B-42EB-B32E-4C0D447DF62FQ36637069-7A07D7A6-97EF-4761-BD08-65C6F0BD460DQ37258596-FA38C657-FFE7-4B10-9DBB-8474CBBB3044Q37322267-4A1F9419-2D1C-4A02-AC8E-056E91334AFDQ38076581-C8FB19A7-803A-4A14-B9EF-4F9A948E6513Q39098823-3728751A-16C7-4631-966D-D686577F7C13Q42509463-6AD4D036-5623-4229-9A69-F4ACC3EF4E62Q44225451-1A6C3B12-3708-433A-ACCD-0556E0DAC5E3Q45265322-2EA39916-DFAC-471F-9778-051385928ADFQ46856268-1AC3DDAD-C729-40BC-944E-C4A849E8F3C0Q47308946-47207B3C-C8A2-49A6-B955-E82B020287FAQ48833095-B8ED1F2B-267F-4D6A-836A-F180FF8334AAQ61633889-D9E816BA-4224-4273-8FCD-3BCCF57522C1Q80207130-F6C65720-38F4-41D3-B41D-A1A2A83B1895Q80870516-AFB9F2FB-089B-42F1-9E68-C802031E2E23
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Shelley J Allen
@ast
Shelley J Allen
@en
Shelley J Allen
@es
Shelley J Allen
@nl
type
label
Shelley J Allen
@ast
Shelley J Allen
@en
Shelley J Allen
@es
Shelley J Allen
@nl
prefLabel
Shelley J Allen
@ast
Shelley J Allen
@en
Shelley J Allen
@es
Shelley J Allen
@nl
P106
P1153
7403050179
P31
P496
0000-0001-7870-740X